Renaissance Technologies’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-27,465
| Closed | -$733K | – | 3670 |
|
2024
Q3 | $733K | Buy |
+27,465
| New | +$733K | ﹤0.01% | 2610 |
|
2024
Q2 | – | Sell |
-45,400
| Closed | -$828K | – | 3624 |
|
2024
Q1 | $828K | Sell |
45,400
-19,300
| -30% | -$352K | ﹤0.01% | 2597 |
|
2023
Q4 | $708K | Sell |
64,700
-86,300
| -57% | -$944K | ﹤0.01% | 2594 |
|
2023
Q3 | $865K | Buy |
151,000
+43,500
| +40% | +$249K | ﹤0.01% | 2401 |
|
2023
Q2 | $833K | Buy |
107,500
+10,700
| +11% | +$82.9K | ﹤0.01% | 2577 |
|
2023
Q1 | $646K | Buy |
96,800
+19,200
| +25% | +$128K | ﹤0.01% | 2735 |
|
2022
Q4 | $694K | Buy |
77,600
+19,300
| +33% | +$173K | ﹤0.01% | 2747 |
|
2022
Q3 | $574K | Buy |
58,300
+25,700
| +79% | +$253K | ﹤0.01% | 2846 |
|
2022
Q2 | $259K | Buy |
+32,600
| New | +$259K | ﹤0.01% | 3530 |
|